Resverlogix Corp Operating Income Over Time
| RVX Stock | CAD 0.1 0.01 5.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Resverlogix Corp Performance and Resverlogix Corp Correlation. Resverlogix |
Cross Equities Operating Income Analysis
Compare Resverlogix Corp and related stocks such as Briacell Therapeutics, Microbix Biosystems, and Perimeter Medical Imaging Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCT | (8.6 K) | (558.8 K) | (424.3 K) | (437.3 K) | (1.4 M) | (1.7 M) | (2.6 M) | (5 K) | 946.4 K | (3.9 M) | (7 M) | (15.3 M) | (23.3 M) | (46 K) | (37.7 M) | (34 M) | (32.3 M) |
| MBX | (100 K) | (1.6 M) | 168.2 K | 475.6 K | 349 K | 148.4 K | (1.5 M) | (742.8 K) | 1.1 M | (524.6 K) | 4.8 M | 2.7 M | (2.7 M) | 3.9 M | (1.6 M) | (1.8 M) | (1.7 M) |
| PINK | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (11.7 M) | (16 M) | (16.1 M) | (22.3 M) | (18.7 M) | (16.8 M) | (17.7 M) |
| AVCN | (29.8 K) | (29.8 K) | (29.8 K) | (29.8 K) | (29.8 K) | (29.8 K) | (29.8 K) | (2.6 M) | (8.4 M) | (23.2 M) | (19 M) | (11.4 M) | (10.4 M) | (7.9 M) | (4.7 M) | (4.2 M) | (4.4 M) |
| LABS | (213.5 K) | (213.5 K) | (213.5 K) | (213.5 K) | (213.5 K) | (213.5 K) | (133.9 K) | (948 K) | (8 M) | 6.9 M | (72.6 M) | (48.9 M) | (29.5 M) | (18.3 M) | (10.8 M) | (9.7 M) | (10.2 M) |
| HEM | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (4.3 M) | (4 M) | (3.7 M) | (2.8 M) | (6.4 M) | (4.7 M) | (7.5 M) | (6.7 M) | (4.6 M) | (2.2 M) | (2 M) | (1.8 M) | (1.9 M) |
Resverlogix Corp and related stocks such as Briacell Therapeutics, Microbix Biosystems, and Perimeter Medical Imaging Operating Income description
Operating Income is the amount of profit realized from Resverlogix Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Resverlogix Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Resverlogix Corp | RVX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 4820 Richard Road |
| Exchange | Toronto Exchange |
CAD 0.095
Other Information on Investing in Resverlogix Stock
Resverlogix Corp financial ratios help investors to determine whether Resverlogix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resverlogix with respect to the benefits of owning Resverlogix Corp security.